3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
5
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Endocrine
1
CNS
1
Conditions
Neuroendocrine Tumors
2
Thyroid Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Recurrence
1
Lung Neoplasms
1
Carcinoma, Small Cell
1
Carcinoma, Ovarian Epithelial
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
3-Iodobenzylguanidine
3
olaparib
1
lutetium Lu 177 dotatate
1
entrectinib
1
entinostat
1
Pemetrexed
1
Paclitaxel
1
Dexamethasone
1
Calcium Dobesilate
1
Cabergoline
1
2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recurrence
×
Pemetrexed
×
Endocrine
×
Clear all
NCT00786552
2011-01-20
Panthera
University Hospital Schleswig-Holstein
Phase 2
Unknown
47 enrolled